NASDAQ:AFMD
$1.21
(
0.83%
)
Friday, 27th Jan 2023
Affimed N.V. Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $1.04 | $1.34 | Friday, 27th Jan 2023 AFMD stock ended at $1.21. This is 0.83% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 3.39% from a day low at $1.18 to a day high of $1.22. |
| 90 days | $1.03 | $2.55 | |
| 52 weeks | $1.03 | $5.10 |
Historical Affimed N.V. prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $1.20 | $1.22 | $1.18 | $1.21 | 720 701 |
| 2023-01-26 | $1.19 | $1.24 | $1.17 | $1.20 | 808 217 |
| 2023-01-25 | $1.17 | $1.20 | $1.14 | $1.19 | 789 379 |
| 2023-01-24 | $1.15 | $1.19 | $1.12 | $1.17 | 2 387 036 |
| 2023-01-23 | $1.22 | $1.26 | $1.16 | $1.16 | 2 358 282 |
| 2023-01-20 | $1.18 | $1.25 | $1.14 | $1.22 | 3 899 948 |
| 2023-01-19 | $1.15 | $1.20 | $1.13 | $1.17 | 1 219 703 |
| 2023-01-18 | $1.14 | $1.19 | $1.13 | $1.18 | 1 489 100 |
| 2023-01-17 | $1.16 | $1.18 | $1.12 | $1.15 | 1 347 400 |
| 2023-01-13 | $1.10 | $1.15 | $1.09 | $1.14 | 1 433 912 |
| 2023-01-12 | $1.08 | $1.14 | $1.04 | $1.13 | 2 189 908 |
| 2023-01-11 | $1.08 | $1.09 | $1.05 | $1.07 | 1 453 549 |
| 2023-01-10 | $1.10 | $1.13 | $1.05 | $1.06 | 1 822 900 |
| 2023-01-09 | $1.15 | $1.17 | $1.05 | $1.08 | 4 580 047 |
| 2023-01-06 | $1.25 | $1.26 | $1.16 | $1.20 | 2 809 019 |
| 2023-01-05 | $1.25 | $1.29 | $1.23 | $1.25 | 669 391 |
| 2023-01-04 | $1.25 | $1.30 | $1.21 | $1.29 | 704 353 |
| 2023-01-03 | $1.32 | $1.34 | $1.20 | $1.21 | 984 917 |
| 2022-12-30 | $1.21 | $1.24 | $1.19 | $1.24 | 560 894 |
| 2022-12-29 | $1.14 | $1.23 | $1.14 | $1.23 | 1 362 477 |
| 2022-12-28 | $1.14 | $1.18 | $1.11 | $1.14 | 747 533 |
| 2022-12-27 | $1.17 | $1.20 | $1.12 | $1.12 | 1 071 820 |
| 2022-12-23 | $1.17 | $1.19 | $1.14 | $1.16 | 668 127 |
| 2022-12-22 | $1.19 | $1.21 | $1.14 | $1.17 | 924 015 |
| 2022-12-21 | $1.15 | $1.24 | $1.14 | $1.19 | 1 546 829 |
| 2022-12-20 | $1.14 | $1.19 | $1.11 | $1.15 | 1 766 891 |
| 2022-12-19 | $1.14 | $1.19 | $1.09 | $1.10 | 2 230 729 |
| 2022-12-16 | $1.12 | $1.14 | $1.05 | $1.12 | 3 606 241 |
| 2022-12-15 | $1.15 | $1.20 | $1.10 | $1.11 | 1 871 696 |
| 2022-12-14 | $1.21 | $1.25 | $1.16 | $1.18 | 3 276 520 |
| 2022-12-13 | $1.39 | $1.41 | $1.18 | $1.20 | 4 329 633 |
| 2022-12-12 | $1.51 | $1.52 | $1.03 | $1.36 | 14 753 549 |
| 2022-12-09 | $2.03 | $2.08 | $2.03 | $2.04 | 907 839 |
| 2022-12-08 | $1.91 | $2.07 | $1.91 | $2.05 | 1 088 585 |
| 2022-12-07 | $1.99 | $2.00 | $1.84 | $1.91 | 3 073 530 |
| 2022-12-06 | $2.10 | $2.13 | $1.97 | $1.99 | 2 073 707 |
| 2022-12-05 | $2.08 | $2.15 | $2.05 | $2.12 | 2 077 487 |
| 2022-12-02 | $2.04 | $2.10 | $1.98 | $2.09 | 2 196 883 |
| 2022-12-01 | $2.13 | $2.19 | $2.03 | $2.04 | 725 369 |
| 2022-11-30 | $2.01 | $2.15 | $1.99 | $2.14 | 2 402 772 |
| 2022-11-29 | $2.01 | $2.07 | $1.95 | $1.99 | 1 069 117 |
| 2022-11-28 | $2.11 | $2.15 | $2.01 | $2.04 | 1 894 519 |
| 2022-11-25 | $2.09 | $2.15 | $2.08 | $2.09 | 531 174 |
| 2022-11-23 | $2.12 | $2.23 | $2.10 | $2.11 | 1 298 060 |
| 2022-11-22 | $2.16 | $2.19 | $2.06 | $2.14 | 1 160 944 |
| 2022-11-21 | $2.01 | $2.16 | $2.00 | $2.11 | 1 242 015 |
| 2022-11-18 | $2.14 | $2.15 | $2.01 | $2.03 | 1 327 703 |
| 2022-11-17 | $2.37 | $2.38 | $2.08 | $2.12 | 2 024 323 |
| 2022-11-16 | $2.29 | $2.51 | $2.25 | $2.45 | 3 065 895 |
| 2022-11-15 | $2.30 | $2.33 | $2.10 | $2.33 | 2 157 508 |
About Affimed N.V.
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
